Td Private Client Wealth LLC Dexcom Inc Transaction History

Td Private Client Wealth LLC

$4.07 Trillion
Q2 2025

A detailed history of Td Private Client Wealth LLC transactions in Dexcom Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 322 shares of DXCM stock, worth $21,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares

322

Previous 493 34.69%

Holding current value

$21,825

Previous $33.7 Million 16.51%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$59.83 - $87.57 $10,230 - $14,974	-171 Reduced 34.69%	322 $28.1 Million
Q1 2025 Apr 29, 2025	BUY	$67.74 - $90.75 $4,064 - $5,445	60 Added 13.86%	493 $33.7 Million
Q4 2024 Feb 11, 2025	BUY	$65.68 - $81.01 $10,968 - $13,528	167 Added 62.78%	433 $33.7 Million
Q3 2024 Nov 18, 2024	SELL	$64.0 - $116.06 $17,536 - $31,800	-274 Reduced 50.74%	266 $17.8 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $59,567 - $75,843	540 New	540 $61.2 Million
Q1 2024 Aug 16, 2024	BUY	$114.22 - $140.1 $1,827 - $2,241	16 Added 2.87%	573 $79.5 Million
Q4 2023 Aug 16, 2024	SELL	$75.49 - $124.16 $1,056 - $1,738	-14 Reduced 2.45%	557 $69.1 Million
Q3 2023 Aug 16, 2024	SELL	$86.06 - $137.93 $7,831 - $12,551	-91 Reduced 13.75%	571 $53.3 Million
Q2 2023 Aug 16, 2024	BUY	$112.47 - $130.98 $6,860 - $7,989	61 Added 10.15%	662 $85.1 Million
Q1 2023 Aug 16, 2024	SELL	$104.0 - $122.92 $1,248 - $1,475	-12 Reduced 1.96%	601 $69.8 Million
Q4 2022 Aug 16, 2024	BUY	$84.98 - $122.67 $14,871 - $21,467	175 Added 39.95%	613 $69.4 Million
Q3 2022 Aug 16, 2024	BUY	$76.35 - $94.18 $5,878 - $7,251	77 Added 21.33%	438 $35.3 Million
Q2 2022 Aug 16, 2024	BUY	$67.99 - $132.89 $17,949 - $35,082	264 Added 272.16%	361 $26.9 Million
Q1 2022 Aug 16, 2024	SELL	$94.08 - $130.2 $3,480 - $4,817	-37 Reduced 27.61%	97 $49.6 Million
Q4 2021 Aug 16, 2024	BUY	$129.87 - $162.82 $3,636 - $4,558	28 Added 26.42%	134 $72 Million
Q3 2021 Aug 16, 2024	SELL	$106.71 - $143.18 $46,312 - $62,140	-434 Reduced 80.37%	106 $58 Million
Q2 2021 Aug 16, 2024	BUY	$80.99 - $107.93 $3,644 - $4,856	45 Added 128.57%	80 $34.2 Million
Q1 2021 Aug 16, 2024	BUY	$84.79 - $104.74 $1,187 - $1,466	14 Added 66.67%	35 $12.6 Million
Q4 2020 Aug 16, 2024	SELL	$78.0 - $104.5 $4,056 - $5,434	-52 Reduced 71.23%	21 $7.76 Million
Q3 2020 Aug 16, 2024	SELL	$95.51 - $112.95 $1,241 - $1,468	-13 Reduced 15.12%	73 $30.1 Million
Q2 2020 Aug 16, 2024	BUY	$62.68 - $105.34 $1,943 - $3,265	31 Added 56.36%	86 $34.9 Million
Q1 2020 Aug 16, 2024	SELL	$47.79 - $75.63 $382 - $605	-8 Reduced 12.7%	55 $14.8 Million
Q4 2019 Aug 16, 2024	SELL	$36.62 - $57.29 $17,467 - $27,327	-477 Reduced 88.33%	63 $13.8 Million

Others Institutions Holding DXCM

# of Institutions

1,110

Shares Held

370M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Dexcom Inc Transaction History